Baxter International (NYSE:BAX) versus INLIF (NASDAQ:INLF) Head to Head Survey

INLIF (NASDAQ:INLF) and Baxter International (NYSE:BAX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership.

Profitability

This table compares INLIF and Baxter International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INLIF	N/A	N/A	N/A
Baxter International	-1.42%	16.96%	5.24%

Analyst Recommendations

This is a breakdown of recent recommendations for INLIF and Baxter International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INLIF	0	0	0	0	0.00
Baxter International	1	6	3	0	2.20

Baxter International has a consensus target price of $30.1111, indicating a potential upside of 27.20%. Given Baxter International’s stronger consensus rating and higher probable upside, analysts clearly believe Baxter International is more favorable than INLIF.

Earnings & Valuation

This table compares INLIF and Baxter International”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INLIF	$15.80 million	1.03	N/A	N/A	N/A
Baxter International	$10.64 billion	1.14	-$649.00 million	($0.30)	-78.91

INLIF has higher earnings, but lower revenue than Baxter International.

Insider & Institutional Ownership

90.2% of Baxter International shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Baxter International beats INLIF on 9 of the 10 factors compared between the two stocks.

About INLIF

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China.

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company’s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.